Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis

Despite progress in prostate cancer (PC) therapeutics, distant metastasis remains a major cause of morbidity and mortality from PC. Thus, there is growing recognition that preventing or delaying PC metastasis holds great potential for substantially improving patient outcomes. Here we show receptor-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yiwu, Zhou, Bo, Qian, Chen, Vasquez, Alex, Kamra, Mohini, Chatterjee, Avradip, Lee, Yeon-Joo, Yuan, Xiaopu, Ellis, Leigh, Di Vizio, Dolores, Posadas, Edwin M., Kyprianou, Natasha, Knudsen, Beatrice S., Shah, Kavita, Murali, Ramachandran, Gertych, Arkadiusz, You, Sungyong, Freeman, Michael R., Yang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813925/
https://www.ncbi.nlm.nih.gov/pubmed/35115556
http://dx.doi.org/10.1038/s41467-022-28340-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813925/
https://www.ncbi.nlm.nih.gov/pubmed/35115556
http://dx.doi.org/10.1038/s41467-022-28340-6

Ejemplares similares